{"id":206305,"date":"2010-01-21T00:20:20","date_gmt":"2010-01-21T05:20:20","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=59364"},"modified":"2010-01-21T00:20:20","modified_gmt":"2010-01-21T05:20:20","slug":"dendreon%e2%80%99s-new-operations-man-acucela-enters-fast-growth-phase-jp-morgan-recap-more-seattle-area-life-sciences-news","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/206305","title":{"rendered":"Dendreon\u2019s New Operations Man, Acucela Enters Fast Growth Phase, JP Morgan Recap, &amp; More Seattle-Area Life Sciences News"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Roundup\/\">Roundup<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Biotech\/\">Biotech<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/people\/\">people<\/a><\/div>\n<p>\t\t<strong>Luke Timmerman wrote:<\/strong><\/p>\n<p>News flow was light on the biotech beat this week, partly because of the MLK Day holiday, and everybody needed a little rest after the networking frenzy at the JP Morgan Healthcare Conference.<\/p>\n<p>&#8212;One of the more interesting interviews I had last week at the JP Morgan conference was with Hans Bishop, the new chief operating officer for Seattle-based <strong>Dendreon<\/strong> (NASDAQ: <a href=\"http:\/\/finance.yahoo.com\/q?s=DNDN\">DNDN<\/a>). He talked about <a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/01\/19\/dendreons-new-operations-man-hans-bishop-aims-to-keep-provenge-trains-running-on-time\/\">manufacturing capacity, the need to hire a marketing ace, and even how to correctly pronounce his name<\/a>.<\/p>\n<p>&#8212;Bothell, WA-based <strong>Acucela<\/strong> has quietly embarked on an ambitious growth plan this year. CEO Ryo Kubota told me in an exclusive interview that the company is <a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/01\/20\/acucela-enters-fast-growth-phase-as-macular-degeneration-drug-advances-to-key-trial\/\">planning to expand its staff from 40 to about 100 this year<\/a> as it advances its novel drug for age-related macular degeneration further along in clinical trials.<\/p>\n<p>&#8212;Instead of doing the usual recap on the <strong>JP Morgan Healthcare Conference<\/strong> like every other news outlet which said the mood was upbeat, I ruminated on <a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/01\/15\/the-value-of-bumping-into-people-in-the-hall-a-lesson-from-the-jp-morgan-healthcare-conference\/\">the value of all the impromptu meetings that happen when so many people gather and pool their energy in one place.<\/a><\/p>\n<p>&#8212;We are getting close to the end of the amazing series of editorials we&#8217;ve been been running daily from Xconomists and other technology leaders who are offering their views on the big innovations of the coming decade. This past week, we ran <a href=\"http:\/\/www.xconomy.com\/national\/2010\/01\/14\/genomic-advances-of-the-2000s-will-demand-an-informatics-revolution-in-the-2010s\/\">a piece on innovations in genomics<\/a> from <strong>Eric Schadt<\/strong>, the chief scientific officer of Pacific Biosciences and a co-founder of Sage Bionetworks, as well as a great editorial about <a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/01\/15\/can-molecular-medicine-survive-its-teenage-years-and-reach-its-potential-this-decade\/\">the future of molecular medicine<\/a> from <strong>Matt O&#8217;Donnell<\/strong>, the dean of the University of Washington College of Engineering.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/01\/21\/dendreons-new-operations-man-acucela-enters-fast-growth-phase-jp-morgan-recap-more-seattle-area-life-sciences-news\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Dendreon&#8217;s%20New%20Operations%20Man,%20Acucela%20Enters%20Fast%20Growth%20Phase,%20JP%20Morgan%20Recap,%20&#038;%20More...%20http:\/\/xconomy.com\/?p=59364\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/seattle\/2010\/01\/21\/dendreons-new-operations-man-acucela-enters-fast-growth-phase-jp-morgan-recap-more-seattle-area-life-sciences-news\/&#038;t=Dendreon&#8217;s%20New%20Operations%20Man,%20Acucela%20Enters%20Fast%20Growth%20Phase,%20JP%20Morgan%20Recap,%20&#038;%20More%20Seattle-Area%20Life%20Sciences%20News\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/seattle\/2010\/01\/21\/dendreons-new-operations-man-acucela-enters-fast-growth-phase-jp-morgan-recap-more-seattle-area-life-sciences-news\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Dendreon%26%238217%3Bs+New+Operations+Man%2C+Acucela+Enters+Fast+Growth+Phase%2C+JP+Morgan+Recap%2C+%26%23038%3B+More+Seattle-Area+Life+Sciences+News&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fseattle%2F2010%2F01%2F21%2Fdendreons-new-operations-man-acucela-enters-fast-growth-phase-jp-morgan-recap-more-seattle-area-life-sciences-news%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=3de936bb240188711310d69ec0f1ad04&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=3de936bb240188711310d69ec0f1ad04&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/4iLOAYv5syBCXwEACeixBspxai8\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/4iLOAYv5syBCXwEACeixBspxai8\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/4iLOAYv5syBCXwEACeixBspxai8\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/4iLOAYv5syBCXwEACeixBspxai8\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/YIAOudC4bI4\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roundup, Biotech, people Luke Timmerman wrote: News flow was light on the biotech beat this week, partly because of the MLK Day holiday, and everybody needed a little rest after the networking frenzy at the JP Morgan Healthcare Conference. &#8212;One of the more interesting interviews I had last week at the JP Morgan conference was [&hellip;]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-206305","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/206305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=206305"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/206305\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=206305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=206305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=206305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}